The largest database of trusted experimental protocols
Sourced in United States, Italy

IGF-II is a laboratory equipment product manufactured by Thermo Fisher Scientific. It is used for the detection and quantification of insulin-like growth factor II (IGF-II) in biological samples. The core function of IGF-II is to enable researchers and scientists to analyze and measure the levels of this important signaling protein in their experiments and studies.

Automatically generated - may contain errors

13 protocols using igf 2

1

Co-culturing Liver Progenitor Cells with hAECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPCs and hAECs were co-cultured in six-well plates at a 1:1 ratio with a total of
100,000 cells seeded per well. A culture consisting of only LPCs served as a
control. These cultures were maintained in DMEM/F12 supplemented with 30 ng/ml
insulin growth factor-II (IGF-II), 50 ng/ml EGF, 10 μg/ml insulin, 100 U/ml
penicillin and streptomycin, and 10% FBS. For hAEC-CM treatment, LPCs were
seeded in tissue culture plates (six, 24, and 96 well) at a density of 8.3 ×
103 cells/cm2 in Roswell Park Memorial Institute
Medium (RPMI) 1640 medium GlutaMAX (Gibco) with 10% FBS, 30 ng/ml IGF-II (Sino
Biological Inc., Beijing, China), 50 ng/ml EGF, and 10 μg/ml insulin (Sigma
Aldrich). Medium was changed 3 days later to control medium, hAEC-CM, or control
medium consisted of RPMI GlutaMax, 50% Dulbecco’s phosphate-buffered saline
(Gibco) containing 5% FBS, 30 ng/ml IGF-II, 50 ng/ml EGF, 10 μg/ml insulin, and
100 U/ml penicillin and streptomycin (Gibco); hAEC-CM was RPMI GlutaMax, 50%
hAEC-CM, 5% FBS, 30 ng/ml IGF-II, 50 ng/ml EGF, 10 μg/ml insulin, and 100U/ml
penicillin and streptomycin. Cultures were maintained at 37°C in 95% humidity
and 5% carbon dioxide with the medium changed every 3 days.
+ Open protocol
+ Expand
2

Functional Regulation of miRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hsa-miR-483-5p mimic, YM00473215-ADA, mimic control, YM00479902-ADA, inhibitors hsa-miR-675-5p, 427419-00, hsa-miR-675-3p, 427420-00, hsa-miR-483-5p, 427155-00, hsa-miR-483-3p, 427154-00, hsa-miR-204-5p, 426934-00, hsa-miR-135-5p, 426790-00, hsa-miR-10a-5p, 426651-00, hsa-miR-9-5p, 427460-00, hsa-miR-9-3p, 427461-00, Control B, 199021-00 are from Qiagen, Germantown, MD, USA. Ceritinib, S7083, linsitinib, S1091, entrectinib, S7998, GSK1904529A, S1093, picropodophyllin, S7668 were obtained from Selleck Chemicals, Houston, TX, USA; GSK1838705A, SML0995, was purchased from Millipore-Sigma, Burlington, MA, USA. The primers used for miRNA and mRNA quantification were miR-99b-5p, 4,427,975, miR-483-5p, 4,427,975, miR-675-5p, 4,427,975, IGF-2, 4,331,182, GAPDH, 4,331,182, ThermoFisher Scientific, Waltham, MA, USA.
+ Open protocol
+ Expand
3

RNA Isolation and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA isolated using QIAshredder and RNeasy Plus Mini Kit (both from Qiagen), cDNA was made with blend of oligo(dT) and random hexamer primers and iScript cDNA synthesis kit (Bio-Rad Laboratories). Quantitative real-time PCR was performed with cDNA using a TaqMan Universal PCR Master Mix (Thermo Fisher Scientific) on the real-time C1000 thermal cycler CFX384 (Bio-Rad). Primer/probes used for analysis were Igf1 (Rn00710306_m1), Igf2 (Rn01454518_m1), Igf1r (Rn00583837_m1), Insr (Rn00567070_m1), and Actb (Rn00667869_m1), all from Thermo Fisher Scientific. Each sample was normalized to β-actin.
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins from the blood samples of AS patients and HVSMCs were isolated using RIPA lysis buffer containing a protease inhibitor (Sbjbio® life science). The concentrations of extracted proteins were determined with a BCA protein assay kit (Sbjbio® life science). Then, polyacrylamide gels were used to separate protein with a SureLock Midi-Cell Electrophoresis System. After blocking the aspecific signals using skimmed milk (Yili, Beijing, China), polyvinylidene fluoride membranes with protein bands were incubated with the primary antibodies against proliferating cell nuclear antigen (PCNA) (#13-3900; 1:5000; Thermo Fisher, Waltham, MA, USA), matrix metalloprotein 2 (MMP2) (#436000; 1:250; Thermo Fisher), IGF2 (#MA5-17096; 1:1,000; Thermo Fisher), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (#MA1-16757; 1:2,000; Thermo Fisher). After being exposed to eyoECL Plus (Beyotime, Shanghai, China), the visualized blots were analyzed using Image J software.
+ Open protocol
+ Expand
5

Optimal Cytokine Conditions for Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-2 (Miltenyi Biotec); IL-21, IL-6, IFN-α, TGF-β3, SDF1α, Osteoprotegerin, M-CSF, Osteopontin, SCF, MIF, IGF-BP2, IGF-II, and Activin A (PeproTech); Jagged-1, ANGPT1, VEGF-165 and VEGF-121 (R&D Systems); Multimeric-APRIL (Caltag); goat anti-human IgM & IgG F(ab′)2 fragments (Jackson ImmunoResearch); Hybridomax hybridoma growth supplement (Gentaur); Lipid Mixture 1, chemically defined (200×) and MEM Amino Acids Solution (50×) (Sigma-Aldrich); SB525334 (Selleckchem).
+ Open protocol
+ Expand
6

Hepatocyte differentiation and modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untransformed differentiated hepatocytes [18 ] were grown in RPMI 1640 with 10% FBS (GIBCO® Life Technology, Monza, Italy), 50 ng/ml EGF, 30 ng/ml IGF II (PeproTech Inc., Rocky Hill, NJ, USA), 10 μg/ml insulin (Roche, Mannheim, Germany) and antibiotics, on collagen I (GIBCO® Life Technology, Monza, Italy) coated dishes. When indicated, cells were treated with 5 μM TGFβ1 for 24 h (PeproTech Inc., Rocky Hill, NJ, USA), according to [19 (link)], and/or with 4 μM DNA-methyltransferases inhibitor 5-Azacytidine (5-Aza; Sigma-aldrich, Sant Louis, MO, USA).
+ Open protocol
+ Expand
7

Schwann Cell Survival Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Schwann cells from P1 STAT3 cKO and WT mice were assayed as in Meier et al. (1999 (link)). Cells were plated at low density (200 cells/coverslip) or high density (3000 cells/coverslip. After 3 h at 37°C and 5% CO2, one set of coverslips from each animal was fixed immediately for immunolabeling to obtain a reference point for the quantification of survival at later time points. The remaining sets were topped up with 400 μl of defined simple medium (sDM) (Meier et al., 1999 (link)) alone or sDM containing 1.6 ng/ml IGF-II (Peprotech), 0.8 ng/ml PDGF-BB (Peprotech), and 0.8 ng/ml NT-3 (Regeneron Pharmaceuticals), or conditioned medium, and cultured for 48 or 72 h. Then, cells were fixed using 4% PFA for 10 min, labeled with S100 antibodies and Hoechst dye, and the number of surviving Schwann cells counted. Survival percentage is the number of living cells present at 48 and 72 h as a percentage of the number of cells that had attached to the substrate in sister cultures at 3 h. sDM consists of 1:1 DMEM and Ham's F-12 supplemented with BSA (350 μg/ml). Schwann cell conditioned medium was prepared as previously described (Meier et al., 1999 (link)).
+ Open protocol
+ Expand
8

Sphere Formation and Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines (100 cells/50 μL/well) were cultured in DMEM/F-12 supplemented with 10% FBS and SphereMax (Wako) using a 96-well ultra-low attachment plate (Corning, NY, USA) for 10 days. CM (25 μL) was added to each well. The number of colonies (size > 100 μm) was counted under a microscope, and the total cell viability was evaluated by analyzing cellular ATP activity using a Cell Titer-Glo Luminescent Cell Viability Assay Kit (Promega, Madison, WI, USA).
Recombinant OPN, HB-EGF, OSM, GRO-a, IL-6, CCL1 (I309), TNF-α, IL-1β, C5a, IGF-II, IGF-BP3, FGF1, VEGF-C, PIGF1, EFEMP1, and EGF were purchased from Peprotech (Rocky Hill, NJ, USA), Wako, or R&D Systems (Minneapolis, MN, USA), and all cytokines were added at a final concentration of 10 ng/mL.
+ Open protocol
+ Expand
9

ME-CSCs Differentiation into Keratinocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To study whether ME-CSCs can differentiate into keratinocyte-like cells, they were plated at a density of 3 × 103 cells/cm² in a 12-well and cultivated in DMEM low glucose (Sigma-Aldrich) containing 10% FCS, keratinocyte growth factor (KGF, 10 ng/ml; Peprotech) and epidermal growth factor (EGF, 20 ng/ml; Peprotech). After 3 days of culture, hepatocytes growth factor (HGF, 10 ng/ml; Peprotech) and insulin-like growth factor-2 (IGF-II, 60 ng/ml; Peprotech) were added. ACSCs cells served as control. After 14 days, RNA isolation and immunocytochemical stainings were performed as described above.
+ Open protocol
+ Expand
10

Hepatocyte Culture on Hydrogel Matrices

Check if the same lab product or an alternative is used in the 5 most similar protocols
RLSCs [17 (link)] were grown in DMEM (Dulbecco's Modified Eagle's Medium) (GIBCO Life Technology, Monza, Italy) with 10% FBS (Sigma Aldrich, St. Louis, MO), 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO), and antibiotics on collagen I (GIBCO Life Technology, Monza, Italy) coated dishes (BD Falcon, Franklin LAkes, NJ, USA) and on 0.4 kPa and 80 kPa hydrogels obtained as described above. Nontumorigenic murine MMH/E14 and WT/3A hepatocytes [19 (link), 20 (link)] were grown in RPMI 1640 with 10% FBS (GIBCO Life Technology, Monza, Italy), 50 ng/mL EGF, 30 ng/mL IGF II (PeproTech Inc., Rocky Hill, NJ, USA), 10 μg/mL insulin (Roche, Mannheim, Germany), and antibiotics, on collagen I (GIBCO Life Technology, Monza, Italy) coated dishes (BD Falcon, Franklin Lakes, NJ, USA) and on 0.4 kPa and 80 kPa hydrogels obtained as described above. 200.000 cells were seeded on each 25 mm coverslip with hydrogel. The morphological analysis was performed by phase-contrast microscopy.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!